Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sensus Healthcare Inc (NQ: SRTS )

3.250 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 3.250
Bid (Size) 1.310 (1)
Ask (Size) 5.200 (2)
Prev. Close 3.250
Today's Range 3.250 - 3.250
52wk Range 1.790 - 5.380
Shares Outstanding 16,619,619
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sensus Healthcare to Participate in the 36th Annual Roth Conference
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
From Sensus Healthcare, Inc.
Via GlobeNewswire

Performance

YTD
+30.52%
+30.52%
1 Month
-9.72%
-9.72%
3 Month
+14.44%
+14.44%
6 Month
+32.65%
+32.65%
1 Year
-37.74%
-37.74%

More News

Read More
3 Stocks to Buy That Are Up 100% or More in 2024
Via InvestorPlace
Sensus Healthcare Inc. (NASDAQ: SRTS) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Recap: Sensus Healthcare Q4 Earnings
Via Benzinga
Earnings Scheduled For February 8, 2024
Via Benzinga
Earnings Preview For Sensus Healthcare
Via Benzinga
Sensus Healthcare Inc. (NASDAQ: SRTS) Near the Top of Equities by Percentage Gain on 1/23
Via Investor Brand Network
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
From Sensus Healthcare, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare: Q3 Earnings Insights
Via Benzinga
Preview: Sensus Healthcare's Earnings
Via Benzinga
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
From Sensus Healthcare, Inc.
Via GlobeNewswire
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
From Sensus Healthcare, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023
From Sensus Healthcare, Inc.
Via GlobeNewswire
Earnings Scheduled For November 9, 2023
Via Benzinga
Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital
From Sensus Healthcare, Inc.
Via GlobeNewswire
7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.